<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04970000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P01112</UniProt_ID>
  <Seq_Length>189</Seq_Length>
  <Molecule_Weight>21298</Molecule_Weight>
  <KEGG_ID>hsa:3265</KEGG_ID>
  <Orthology_ID>K02833</Orthology_ID>
  <EBI_ID>EBI-350145</EBI_ID>
  <Function_Summary>Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.</Function_Summary>
  <Pfam_ID>PF00071:Ras</Pfam_ID>
  <Allosteric_Activator_Count>3</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>5</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Ha-Ras</Alias>
      <Alias>Transforming protein p21</Alias>
      <Alias>GTPase HRas, N-terminally processed</Alias>
      <Alias>c-H-ras</Alias>
      <Alias>H-Ras-1</Alias>
      <Alias>p21ras</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with GTP, guanosine triphosphate.</Detail>
      <Keyword>GTP binding</Keyword>
      <Ontology_ID>GO:0005525</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: GTP + H2O = GDP + phosphate.</Detail>
      <Keyword>GTPase activity</Keyword>
      <Ontology_ID>GO:0003924</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxy function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.</Detail>
      <Keyword>Protein C-terminus binding</Keyword>
      <Ontology_ID>GO:0008022</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>13</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>117</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>61</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>13</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>61</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>63</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>22</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>58</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.</Detail>
      <Keyword>Insulin receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0008286</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cascade of at least three protein kinase activities culminating in the phosphorylation and activation of a MAP kinase. MAPKKK cascades lie downstream of numerous signaling pathways.</Detail>
      <Keyword>MAPKKK cascade</Keyword>
      <Ontology_ID>GO:0000165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the nerve growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Nerve growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048011</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade.</Detail>
      <Keyword>Positive regulation of JNK cascade</Keyword>
      <Ontology_ID>GO:0046330</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.</Detail>
      <Keyword>Positive regulation of ERK1 and ERK2 cascade</Keyword>
      <Ontology_ID>GO:0070374</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.</Detail>
      <Keyword>Synaptic transmission</Keyword>
      <Ontology_ID>GO:0007268</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.</Detail>
      <Keyword>Axon guidance</Keyword>
      <Ontology_ID>GO:0007411</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme MAP kinase kinase by phosphorylation by a MAPKKK.</Detail>
      <Keyword>Activation of MAPKK activity</Keyword>
      <Ontology_ID>GO:0000186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Morphogenesis of an organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.</Detail>
      <Keyword>Organ morphogenesis</Keyword>
      <Ontology_ID>GO:0009887</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cell aging process stimulated in response to cellular stress, whereby normal cells lose the ability to divide through irreversible cell cycle arrest.</Detail>
      <Keyword>Cellular senescence</Keyword>
      <Ontology_ID>GO:0090398</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cell cycle checkpoint that blocks entry into S phase of the mitotic cell cycle.</Detail>
      <Keyword>Mitotic cell cycle G1/S transition checkpoint</Keyword>
      <Ontology_ID>GO:0031575</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).</Detail>
      <Keyword>Cell cycle arrest</Keyword>
      <Ontology_ID>GO:0007050</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of transcription from the RNA polymerase II promoter.</Detail>
      <Keyword>Positive regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0045944</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of epithelial cell proliferation.</Detail>
      <Keyword>Positive regulation of epithelial cell proliferation</Keyword>
      <Ontology_ID>GO:0050679</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.</Detail>
      <Keyword>Positive regulation of protein phosphorylation</Keyword>
      <Ontology_ID>GO:0001934</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Fibroblast growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0008543</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate or extent of cell proliferation.</Detail>
      <Keyword>Negative regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008285</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The movement of a leukocyte within or between different tissues and organs of the body.</Detail>
      <Keyword>Leukocyte migration</Keyword>
      <Ontology_ID>GO:0050900</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of an epidermal growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Epidermal growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0007173</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.</Detail>
      <Keyword>Ras protein signal transduction</Keyword>
      <Ontology_ID>GO:0007265</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of DNA replication.</Detail>
      <Keyword>Positive regulation of DNA replication</Keyword>
      <Ontology_ID>GO:0045740</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylthreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>186</Position>
      <PTM_Type>Cysteine methyl ester</PTM_Type>
    </PTM>
    <PTM>
      <Position>118</Position>
      <PTM_Type>S-nitrosocysteine</PTM_Type>
    </PTM>
    <PTM>
      <Position>1</Position>
      <PTM_Type>N-acetylmethionine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKLNPPDESGPGCMSCKCVLS</Protein_Seq>
    <DNA_Seq>TGCCCTGCGCCCGCAACCCGAGCCGCACCCGCCGCGGACGGAGCCCATGCGCGGGGCGAACCGCGCGCCCCCGCCCCCGCCCCGCCCCGGCCTCGGCCCCGGCCCTGGCCCCGGGGGCAGTCGCGCCTGTGAACGGTGGGGCAGGAGACCCTGTAGGAGGACCCCGGGCCGCAGGCCCCTGAGGAGCGATGACGGAATATAAGCTGGTGGTGGTGGGCGCCGGCGGTGTGGGCAAGAGTGCGCTGACCATCCAGCTGATCCAGAACCATTTTGTGGACGAATACGACCCCACTATAGAGGATTCCTACCGGAAGCAGGTGGTCATTGATGGGGAGACGTGCCTGTTGGACATCCTGGATACCGCCGGCCAGGAGGAGTACAGCGCCATGCGGGACCAGTACATGCGCACCGGGGAGGGCTTCCTGTGTGTGTTTGCCATCAACAACACCAAGTCTTTTGAGGACATCCACCAGTACAGGGAGCAGATCAAACGGGTGAAGGACTCGGATGACGTGCCCATGGTGCTGGTGGGGAACAAGTGTGACCTGGCTGCACGCACTGTGGAATCTCGGCAGGCTCAGGACCTCGCCCGAAGCTACGGCATCCCCTACATCGAGACCTCGGCCAAGACCCGGCAGGGAGTGGAGGATGCCTTCTACACGTTGGTGCGTGAGATCCGGCAGCACAAGCTGCGGAAGCTGAACCCTCCTGATGAGAGTGGCCCCGGCTGCATGAGCTGCAAGTGTGTGCTCTCCTGACGCAGGTGAGGGGGACTCCCAGGGCGGCCGCCACGCCCACCGGATGACCCCGGCTCCCCGCCCCTGCCGGTCTCCTGGCCTGCGGTCAGCAGCCTCCCTTGTGCCCCGCCCAGCACAAGCTCAGGACATGGAGGTGCCGGATGCAGGAAGGAGGTGCAGACGGAAGGAGGAGGAAGGAAGGACGGAAGCAAGGAAGGAAGGAAGGGCTGCTGGAGCCCAGTCACCCCGGGACCGTGGGCCGAGGTGACTGCAGACCCTCCCAGGGAGGCTGTGCACAGACTGTCTTGAACATCCCAAATGCCACCGGAACCCCAGCCCTTAGCTCCCCTCCCAGGCCTCTGTGGGCCCTTGTCGGGCACAGATGGGATCACAGTAAATTATTGGATGGTCTTGAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Golgi membrane</CellLocal>
      <Ontology_ID>GO:0000139</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Golgi apparatus membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Golgi apparatus</CellLocal>
      <Ontology_ID>GO:0005794</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Perinuclear region of cytoplasm</CellLocal>
      <Ontology_ID>GO:0048471</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>HRAS</Gene_Name>
    <Gene_Alias>HRAS1</Gene_Alias>
    <Gene_ID>3265</Gene_ID>
    <Genbank_ACCN>NM_001130442</Genbank_ACCN>
    <Protein_ACCN>NP_001123914</Protein_ACCN>
    <HGNC_ID>5173</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/3265</Gene_URL>
    <UCSC_ID>uc010qvw.2</UCSC_ID>
    <EMBL_ID>ENSG00000174775</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q9NS23-2</Uniprot_ID>
      <Gene_Name>RASSF1</Gene_Name>
      <EBI_ID>EBI-438698</EBI_ID>
      <PPI_EBI_URL>EBI-350145,EBI-438698</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P42337</Uniprot_ID>
      <Gene_Name>Pik3ca</Gene_Name>
      <EBI_ID>EBI-641748</EBI_ID>
      <PPI_EBI_URL>EBI-350145,EBI-641748</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9EQZ6</Uniprot_ID>
      <Gene_Name>Rapgef4</Gene_Name>
      <EBI_ID>EBI-772212</EBI_ID>
      <PPI_EBI_URL>EBI-350145,EBI-772212</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q13671</Uniprot_ID>
      <Gene_Name>RIN1</Gene_Name>
      <EBI_ID>EBI-366017</EBI_ID>
      <PPI_EBI_URL>EBI-350145,EBI-366017</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q5EBH1-2</Uniprot_ID>
      <Gene_Name>Rassf5</Gene_Name>
      <EBI_ID>EBI-960547</EBI_ID>
      <PPI_EBI_URL>EBI-350145,EBI-960547</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9Z0S9</Uniprot_ID>
      <Gene_Name>Rabac1</Gene_Name>
      <EBI_ID>EBI-476965</EBI_ID>
      <PPI_EBI_URL>EBI-350145,EBI-476965</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q7Z569</Uniprot_ID>
      <Gene_Name>BRAP</Gene_Name>
      <EBI_ID>EBI-349900</EBI_ID>
      <PPI_EBI_URL>EBI-350145,EBI-349900</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P04049</Uniprot_ID>
      <Gene_Name>RAF1</Gene_Name>
      <EBI_ID>EBI-365996</EBI_ID>
      <PPI_EBI_URL>EBI-350145,EBI-365996</PPI_EBI_URL>
      <Experiment_Number>8</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q07889</Uniprot_ID>
      <Gene_Name>SOS1</Gene_Name>
      <EBI_ID>EBI-297487</EBI_ID>
      <PPI_EBI_URL>EBI-350145,EBI-297487</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Thyroid Carcinoma, Follicular, Somatic</Disease_Name>
      <Disease_Detail>Thyroid Cancer</Disease_Detail>
      <Disease_DB>THY059</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_carcinoma_follicular_somatic?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Phakomatosis Pigmentokeratotica</Disease_Name>
      <Disease_Detail>Phakomatosis Pigmentokeratotica</Disease_Detail>
      <Disease_DB>PHK006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/phakomatosis_pigmentokeratotica?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastrointestinal System Disease</Disease_Name>
      <Disease_Detail>Gastrointestinal System Disease</Disease_Detail>
      <Disease_DB>GST050</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastrointestinal_system_disease?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Follicular Thyroid Carcinoma</Disease_Name>
      <Disease_Detail>Follicular Thyroid Carcinoma</Disease_Detail>
      <Disease_DB>FLL032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/follicular_thyroid_carcinoma?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Phacomatosis Pigmentokeratotica</Disease_Name>
      <Disease_Detail>Phacomatosis Pigmentokeratotica</Disease_Detail>
      <Disease_DB>PHC005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/phacomatosis_pigmentokeratotica?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Juvenile Myelomonocytic Leukemia</Disease_Name>
      <Disease_Detail>Juvenile Myelomonocytic Leukemia</Disease_Detail>
      <Disease_DB>JVN004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/juvenile_myelomonocytic_leukemia?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thyroid Cancer</Disease_Name>
      <Disease_Detail>Thyroid Cancer</Disease_Detail>
      <Disease_DB>THY028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_cancer?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bladder Carcinoma</Disease_Name>
      <Disease_Detail>Bladder Cancer</Disease_Detail>
      <Disease_DB>BLD042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bladder_carcinoma?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Noonan Syndrome</Disease_Name>
      <Disease_Detail>Noonan Syndrome</Disease_Detail>
      <Disease_DB>NNN003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/noonan_syndrome?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epidermal Nevus, Somatic</Disease_Name>
      <Disease_Detail>Epidermal Nevus</Disease_Detail>
      <Disease_DB>EPD053</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epidermal_nevus_somatic?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Myeloid Leukemia</Disease_Name>
      <Disease_Detail>Acute Myeloid Leukemia</Disease_Detail>
      <Disease_DB>ACT019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_myeloid_leukemia?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Exanthem</Disease_Name>
      <Disease_Detail>Exanthem</Disease_Detail>
      <Disease_DB>EXN002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/exanthem?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Male Germ Cell Tumor</Disease_Name>
      <Disease_Detail>Male Germ Cell Tumor</Disease_Detail>
      <Disease_DB>MLG083</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/male_germ_cell_tumor?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Neurofibromatosis</Disease_Name>
      <Disease_Detail>Neurofibromatosis</Disease_Detail>
      <Disease_DB>NRF002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/neurofibromatosis?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Costello Syndrome</Disease_Name>
      <Disease_Detail>Costello Syndrome</Disease_Detail>
      <Disease_DB>CST001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/costello_syndrome?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epidermal Nevus</Disease_Name>
      <Disease_Detail>Epidermal Nevus</Disease_Detail>
      <Disease_DB>EPD037</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epidermal_nevus?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nevus Sebaceous, Somatic</Disease_Name>
      <Disease_Detail>Nevus Sebaceous, Somatic</Disease_Detail>
      <Disease_DB>NVS013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nevus_sebaceous_somatic?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Schimmelpenning-Feuerstein-Mims Syndrome, Somatic Mosaic</Disease_Name>
      <Disease_Detail>Schimmelpenning-Feuerstein-Mims Syndrome, Somatic Mosaic</Disease_Detail>
      <Disease_DB>SCH063</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/schimmelpenning_feuerstein_mims_syndrome_somatic_mosaic?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Oral Squamous Cell Carcinoma</Disease_Name>
      <Disease_Detail>Oral Squamous Cell Carcinoma</Disease_Detail>
      <Disease_DB>ORL015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/oral_squamous_cell_carcinoma?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bladder Cancer Susceptibility</Disease_Name>
      <Disease_Detail>Bladder Cancer</Disease_Detail>
      <Disease_DB>BLD101</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bladder_cancer_susceptibility?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sfm Syndrome, Somatic Mosaic</Disease_Name>
      <Disease_Detail>Sfm Syndrome, Somatic Mosaic</Disease_Detail>
      <Disease_DB>SFM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sfm_syndrome_somatic_mosaic?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiofaciocutaneous Syndrome</Disease_Name>
      <Disease_Detail>Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>CRD013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiofaciocutaneous_syndrome?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pulmonic Stenosis</Disease_Name>
      <Disease_Detail>Pulmonic Stenosis</Disease_Detail>
      <Disease_DB>PLM070</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pulmonic_stenosis?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spitz Nevus</Disease_Name>
      <Disease_Detail>Spitz Nevus</Disease_Detail>
      <Disease_DB>SPT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spitz_nevus?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sarcoma</Disease_Name>
      <Disease_Detail>Sarcoma</Disease_Detail>
      <Disease_DB>SRC014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sarcoma?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leopard Syndrome</Disease_Name>
      <Disease_Detail>Leopard Syndrome</Disease_Detail>
      <Disease_DB>LPR002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leopard_syndrome?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Corticobasal Degeneration</Disease_Name>
      <Disease_Detail>Corticobasal Degeneration</Disease_Detail>
      <Disease_DB>CRT033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/corticobasal_degeneration?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congenital Myopathy with Excess of Muscle Spindles</Disease_Name>
      <Disease_Detail>Congenital Myopathy with Excess of Muscle Spindles</Disease_Detail>
      <Disease_DB>CNG387</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congenital_myopathy_with_excess_of_muscle_spindles?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Core Binding Factor Acute Myeloid Leukemia</Disease_Name>
      <Disease_Detail>Core Binding Factor Acute Myeloid Leukemia</Disease_Detail>
      <Disease_DB>CRB138</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/core_binding_factor_acute_myeloid_leukemia?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Medulloblastoma</Disease_Name>
      <Disease_Detail>Medulloblastoma</Disease_Detail>
      <Disease_DB>MDL005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/medulloblastoma?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatic Cancer</Disease_Name>
      <Disease_Detail>Pancreatic Cancer</Disease_Detail>
      <Disease_DB>PNC035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatic_cancer?search=HRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bladder Cancer, Somatic</Disease_Name>
      <Disease_Detail>Bladder Cancer</Disease_Detail>
      <Disease_DB>BLD087</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bladder_cancer_somatic?search=HRAS#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GDP</PDB_Title>
      <PDB_ID>2CE2</PDB_ID>
      <Resolution>1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CE2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Newly Designed Microspectrofluorometer for Kinetic Studies on Protein Crystals in Combination with X-Ray Diffraction</PubMed_Title>
      <Author>Klink, B.U., et al.</Author>
      <Journal>Biophys.J.(2006)91:981</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16698776?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE SOLUTION STRUCTURE AND DYNAMICS OF RAS P21. GDP DETERMINED BY HETERONUCLEAR THREE AND FOUR DIMENSIONAL NMR SPECTROSCOPY</PDB_Title>
      <PDB_ID>1CRP</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CRP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy.</PubMed_Title>
      <Author>Kraulis, P.J., et al.</Author>
      <Journal>Biochemistry(1994)33:3515-3531</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8142349?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras soaked in neat hexane: 1 of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RS3</PDB_ID>
      <Resolution>1.52</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RS3</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES</PDB_Title>
      <PDB_ID>421P</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=421P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules.</PubMed_Title>
      <Author>Krengel, U., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1990)62:539-548</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2199064?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION: STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS OF PROTOONCOGENIC RAS PROTEINS</PDB_Title>
      <PDB_ID>6Q21</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=6Q21</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins.</PubMed_Title>
      <Author>Milburn, M.V., et al.</Author>
      <Journal>Science(1990)247:939-945</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2406906?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES</PDB_Title>
      <PDB_ID>621P</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=621P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules.</PubMed_Title>
      <Author>Krengel, U., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1990)62:539-548</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2199064?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA,GAMMA-IMIDO-GTP</PDB_Title>
      <PDB_ID>1CLU</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CLU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Guanosine triphosphatase stimulation of oncogenic Ras mutants.</PubMed_Title>
      <Author>Ahmadian, M.R., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(1999)96:7065-7070</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10359839?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Allosteric modulation of H-Ras GTPase</PDB_Title>
      <PDB_ID>3K9L</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3K9L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Allosteric modulation of H-Ras GTPase</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES</PDB_Title>
      <PDB_ID>721P</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=721P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules.</PubMed_Title>
      <Author>Krengel, U., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1990)62:539-548</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2199064?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras soaked in 90% R,S,R-bisfuranol: one of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RSL</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RSL</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GTP (2)</PDB_Title>
      <PDB_ID>2CLC</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CLC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Newly Designed Microspectrofluorometer for Kinetic Studies on Protein Crystals in Combination with X-Ray Diffraction</PubMed_Title>
      <Author>Klink, B.U., et al.</Author>
      <Journal>Biophys.J.(2006)91:981</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16698776?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras Set 2 CaCl2/DTT, ordered off</PDB_Title>
      <PDB_ID>4DLV</PDB_ID>
      <Resolution>1.57</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DLV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04400004</ASD_Ligand>
      <PubMed_Title>Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.</PubMed_Title>
      <Author>Holzapfel, G., et al.</Author>
      <Journal>Biochemistry(2012)51:6114-6126</Journal>
      <PubMed_ID>22845804</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION: STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS OF PROTOONCOGENIC RAS PROTEINS</PDB_Title>
      <PDB_ID>4Q21</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4Q21</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins.</PubMed_Title>
      <Author>Milburn, M.V., et al.</Author>
      <Journal>Science(1990)247:939-945</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2406906?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF PLC EPSILON RAS ASSOCIATION DOMAIN WITH HRAS</PDB_Title>
      <PDB_ID>2C5L</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2C5L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and Mechanistic Insights Into Ras Association Domains of Phospholipase C Epsilon</PubMed_Title>
      <Author>Bunney, T.D., et al.</Author>
      <Journal>Mol.Cell(2006)21:495</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16483931?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of H-RasQ61K-GppNHp</PDB_Title>
      <PDB_ID>2RGB</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RGB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Transformation Efficiency of RasQ61 Mutants Linked to Structural Features of the Switch Regions in the Presence of Raf.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Structure(2007)15:1618-1629</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18073111?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Set 1 CaCl2/DTT, ordered off</PDB_Title>
      <PDB_ID>4DLY</PDB_ID>
      <Resolution>1.57</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DLY</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04400004</ASD_Ligand>
      <PubMed_Title>Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.</PubMed_Title>
      <Author>Holzapfel, G., et al.</Author>
      <Journal>Biochemistry(2012)51:6114-6126</Journal>
      <PubMed_ID>22845804</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange factor SOS</PDB_Title>
      <PDB_ID>1NVU</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NVU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange factor SOS</PubMed_Title>
      <Author>Margarit, S.M., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2003)112:685-695</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12628188?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras soaked in 50% 2,2,2-trifluoroethanol: one of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RS2</PDB_ID>
      <Resolution>1.84</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RS2</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras soaked in 50% isopropanol: 1 of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RS7</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RS7</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras Set 1 Ca(OAc)2, on</PDB_Title>
      <PDB_ID>4DLU</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DLU</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.</PubMed_Title>
      <Author>Holzapfel, G., et al.</Author>
      <Journal>Biochemistry(2012)51:6114-6126</Journal>
      <PubMed_ID>22845804</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTALLOGRAPHIC STUDIES ON P21H-RAS USING SYNCHROTRON LAUE METHOD: IMPROVEMENT OF CRYSTAL QUALITY AND MONITORING OF THE GTPASE REACTION AT DIFFERENT TIME POINTS</PDB_Title>
      <PDB_ID>1PLK</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PLK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic studies on p21(H-ras) using the synchrotron Laue method: improvement of crystal quality and monitoring of the GTPase reaction at different time points.</PubMed_Title>
      <Author>Scheidig, A.J., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1994)50:512-520</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15299412?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITH GUANOSINE-5'-[BETA,GAMMA-METHYLENE] TRIPHOSPHATE AND MANGANESE</PDB_Title>
      <PDB_ID>1JAI</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1JAI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The role of the metal ion in the p21ras catalysed GTP-hydrolysis: Mn2+ versus Mg2+.</PubMed_Title>
      <Author>Schweins, T., et al.</Author>
      <Journal>J.Mol.Biol.(1997)266:847-856</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9102473?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the C-HA-RAS Protein Prepared by the Cell-Free Synthesis</PDB_Title>
      <PDB_ID>1IOZ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IOZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Selenomethionine incorporation into a protein by cell-free synthesis</PubMed_Title>
      <Author>Kigawa, T., et al.</Author>
      <Journal>J.STRUCT.FUNCT.GENOM.(2001)2:29-35</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12836672?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the GDP-bound form of the RasG60A mutant</PDB_Title>
      <PDB_ID>1XJ0</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XJ0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of an intermediate for nucleotide exchange by Ras</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV COMPLEX</PDB_Title>
      <PDB_ID>2UZI</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2UZI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Tumour Prevention by a Single Antibody Domain Targeting the Interaction of Signal Transduction Proteins with Ras.</PubMed_Title>
      <Author>Tanaka, T., et al.</Author>
      <Journal>Embo J.(2007)26:3250</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17568777?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-RAY CRYSTAL STRUCTURE ANALYSIS OF THE CATALYTIC DOMAIN OF THE ONCOGENE PRODUCT P21H-RAS COMPLEXED WITH CAGED GTP AND MANT DGPPNHP</PDB_Title>
      <PDB_ID>1GNP</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GNP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray crystal structure analysis of the catalytic domain of the oncogene product p21H-ras complexed with caged GTP and mant dGppNHp.</PubMed_Title>
      <Author>Scheidig, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1995)253:132-150</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7473708?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF P21RAS IN COMPLEX WITH GPPNHP AT 100 K</PDB_Title>
      <PDB_ID>1CTQ</PDB_ID>
      <Resolution>1.26</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CTQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The pre-hydrolysis state of p21(ras) in complex with GTP: new insights into the role of water molecules in the GTP hydrolysis reaction of ras-like proteins.</PubMed_Title>
      <Author>Scheidig, A.J., et al.</Author>
      <Journal>Structure Fold.Des.(1999)7:1311-1324</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10574788?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THREE-DIMENSIONAL STRUCTURES AND PROPERTIES OF A TRANSFORMING AND A NONTRANSFORMING GLY-12 MUTANT OF P21-H-RAS</PDB_Title>
      <PDB_ID>1AGP</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1AGP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras.</PubMed_Title>
      <Author>Franken, S.M., et al.</Author>
      <Journal>Biochemistry(1993)32:8411-8420</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8357792?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras Set 1 CaCl2/DTE, ordered off</PDB_Title>
      <PDB_ID>4DLX</PDB_ID>
      <Resolution>1.73</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DLX</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978005</ASD_Ligand>
      <PubMed_Title>Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.</PubMed_Title>
      <Author>Holzapfel, G., et al.</Author>
      <Journal>Biochemistry(2012)51:6114-6126</Journal>
      <PubMed_ID>22845804</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange factor SOS</PDB_Title>
      <PDB_ID>1NVX</PDB_ID>
      <Resolution>3.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NVX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange factor SOS</PubMed_Title>
      <Author>Margarit, S.M., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2003)112:685-695</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12628188?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange factor SOS</PDB_Title>
      <PDB_ID>1NVW</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NVW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange factor SOS</PubMed_Title>
      <Author>Margarit, S.M., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2003)112:685-695</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12628188?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras Set 2 Ca(OAc)2/DTT, on</PDB_Title>
      <PDB_ID>4DLW</PDB_ID>
      <Resolution>1.72</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DLW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.</PubMed_Title>
      <Author>Holzapfel, G., et al.</Author>
      <Journal>Biochemistry(2012)51:6114-6126</Journal>
      <PubMed_ID>22845804</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES</PDB_Title>
      <PDB_ID>221P</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=221P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules.</PubMed_Title>
      <Author>Krengel, U., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1990)62:539-548</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2199064?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of H-RasQ61L-GppNHp</PDB_Title>
      <PDB_ID>2RGD</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RGD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Transformation Efficiency of RasQ61 Mutants Linked to Structural Features of the Switch Regions in the Presence of Raf.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Structure(2007)15:1618-1629</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18073111?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-RasQ61L with allosteric switch in the on state</PDB_Title>
      <PDB_ID>3OIU</PDB_ID>
      <Resolution>1.32</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OIU</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Allosteric Modulation of Ras-GTP Is Linked to Signal Transduction through RAF Kinase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Biol.Chem.(2011)286:3323-3331</Journal>
      <PubMed_ID>21098031</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complex of Ras with cyclen</PDB_Title>
      <PDB_ID>3L8Y</PDB_ID>
      <Resolution>2.02</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3L8Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Stabilizing a weak binding state for effectors in the human ras protein by cyclen complexes</PubMed_Title>
      <Author>Rosnizeck, I.C., et al.</Author>
      <Journal>Angew.Chem.Int.Ed.Engl.(2010)49:3830-3833</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20401883?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of wt H-Ras-GppNHp bound to the RBD of Raf Kinase</PDB_Title>
      <PDB_ID>4G0N</PDB_ID>
      <Resolution>2.45</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4G0N</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04400004;ASD11630001</ASD_Ligand>
      <PubMed_Title>Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD.</PubMed_Title>
      <Author>Fetics, S.K., et al.</Author>
      <Journal>Structure(2015)23:505-516</Journal>
      <PubMed_ID>25684575</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GppNHp-bound H-Ras G60A mutant</PDB_Title>
      <PDB_ID>1XCM</PDB_ID>
      <Resolution>1.84</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XCM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the GppNHp-bound form of the RasG60A mutant</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure analysis of a fluorescent form of H-Ras p21 in complex with R-caged GTP</PDB_Title>
      <PDB_ID>2EVW</PDB_ID>
      <Resolution>1.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2EVW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A newly designed microspectrofluorometer for kinetic studies on protein crystals in combination with x-ray diffraction.</PubMed_Title>
      <Author>Klink, B.U., et al.</Author>
      <Journal>Biophys.J.(2006)91:981-992</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16698776?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH S-CAGED GTP</PDB_Title>
      <PDB_ID>2CL6</PDB_ID>
      <Resolution>1.24</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CL6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Newly Designed Microspectrofluorometer for Kinetic Studies on Protein Crystals in Combination with X-Ray Diffraction.</PubMed_Title>
      <Author>Klink, B.U., et al.</Author>
      <Journal>Biophys.J.(2006)91:981</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16698776?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THREE-DIMENSIONAL STRUCTURES AND PROPERTIES OF A TRANSFORMING AND A NONTRANSFORMING GLYCINE-12 MUTANT OF P21H-RAS</PDB_Title>
      <PDB_ID>821P</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=821P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras.</PubMed_Title>
      <Author>Franken, S.M., et al.</Author>
      <Journal>Biochemistry(1993)32:8411-8420</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8357792?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras PEG 400/Ca(OAc)2, ordered off</PDB_Title>
      <PDB_ID>4DLR</PDB_ID>
      <Resolution>1.32</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DLR</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978005</ASD_Ligand>
      <PubMed_Title>Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.</PubMed_Title>
      <Author>Holzapfel, G., et al.</Author>
      <Journal>Biochemistry(2012)51:6114-6126</Journal>
      <PubMed_ID>22845804</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the Q61G mutant of Ras in the GDP-bound form</PDB_Title>
      <PDB_ID>1ZVQ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ZVQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of a transient intermediate for GTP hydrolysis by ras.</PubMed_Title>
      <Author>Ford, B., et al.</Author>
      <Journal>Structure(2006)14:427-436</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16531227?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras Set 1 CaCl2 'Mixed'</PDB_Title>
      <PDB_ID>4DLS</PDB_ID>
      <Resolution>1.82</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DLS</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00240009</ASD_Ligand>
      <PubMed_Title>Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.</PubMed_Title>
      <Author>Holzapfel, G., et al.</Author>
      <Journal>Biochemistry(2012)51:6114-6126</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22845804?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN C-HA-RAS(1-171)(DOT)GDP, NMR, MINIMIZED AVERAGE STRUCTURE</PDB_Title>
      <PDB_ID>1AA9</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1AA9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.</PubMed_Title>
      <Author>Ito, Y., et al.</Author>
      <Journal>Biochemistry(1997)36:9109-9119</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9230043?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange factor SOS</PDB_Title>
      <PDB_ID>1NVV</PDB_ID>
      <Resolution>2.18</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NVV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural evidence for feedback activation by RasGTP of the     Ras-specific nucleotide exchange factor SOS</PubMed_Title>
      <Author>Margarit, S.M., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2003)112:685-695</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12628188?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GPPNHP</PDB_Title>
      <PDB_ID>2CL0</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CL0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Newly Designed Microspectrofluorometer for Kinetic Studies on Protein Crystals in Combination with X-Ray Diffraction</PubMed_Title>
      <Author>Klink, B.U., et al.</Author>
      <Journal>Biophys.J.(2006)91:981</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16698776?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras Set 2 Ca(OAc)2/DTE, ordered off</PDB_Title>
      <PDB_ID>4DLZ</PDB_ID>
      <Resolution>1.66</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DLZ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978005</ASD_Ligand>
      <PubMed_Title>Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.</PubMed_Title>
      <Author>Holzapfel, G., et al.</Author>
      <Journal>Biochemistry(2012)51:6114-6126</Journal>
      <PubMed_ID>22845804</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>COMPLEX OF HUMAN H-RAS WITH HUMAN SOS-1</PDB_Title>
      <PDB_ID>1BKD</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BKD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structural basis of the activation of Ras by Sos.</PubMed_Title>
      <Author>Boriack-Sjodin, P.A., et al.</Author>
      <Journal>Nature(1998)394:337-343</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9690470?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF THE CATALYTIC DOMAINS OF NORMAL RAS PROTEIN AND AN ONCOGENIC MUTANT COMPLEXED WITH GSP</PDB_Title>
      <PDB_ID>1Q21</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Q21</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.</PubMed_Title>
      <Author>Tong, L.A., et al.</Author>
      <Journal>J.Mol.Biol.(1991)217:503-516</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1899707?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the GTP-bound form of RasQ61G</PDB_Title>
      <PDB_ID>1ZW6</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ZW6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of a transient intermediate for GTP hydrolysis by ras.</PubMed_Title>
      <Author>Ford, B., et al.</Author>
      <Journal>Structure(2006)14:427-436</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16531227?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>RAS-RASGAP COMPLEX</PDB_Title>
      <PDB_ID>1WQ1</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WQ1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.</PubMed_Title>
      <Author>Scheffzek, K., et al.</Author>
      <Journal>Science(1997)277:333-338</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9219684?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of a ternary Ras:SOS:Ras*GDP complex</PDB_Title>
      <PDB_ID>1XD2</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XD2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural analysis of autoinhibition in the ras activator son of sevenless.</PubMed_Title>
      <Author>Sondermann, H., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2004)119:393-405</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15507210?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of H-Ras with Thr50 replaced by Isoleucine</PDB_Title>
      <PDB_ID>3I3S</PDB_ID>
      <Resolution>1.36</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3I3S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A restricted spectrum of NRAS mutations causes Noonan syndrome.</PubMed_Title>
      <Author>Cirstea, I.C., et al.</Author>
      <Journal>Nat.Genet.(2010)42:27-29</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19966803?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of H-RasQ61I-GppNHp, trigonal crystal form</PDB_Title>
      <PDB_ID>2RGG</PDB_ID>
      <Resolution>1.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RGG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Transformation Efficiency of RasQ61 Mutants Linked to Structural Features of the Switch Regions in the Presence of Raf.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Structure(2007)15:1618-1629</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18073111?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras Set 2 Ca(OAc)2, on</PDB_Title>
      <PDB_ID>4DLT</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DLT</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.</PubMed_Title>
      <Author>Holzapfel, G., et al.</Author>
      <Journal>Biochemistry(2012)51:6114-6126</Journal>
      <PubMed_ID>22845804</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITH GUANOSINE-5'-[BETA,GAMMA-METHYLENE] TRIPHOSPHATE AND MAGNESIUM</PDB_Title>
      <PDB_ID>1JAH</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1JAH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The role of the metal ion in the p21ras catalysed GTP-hydrolysis: Mn2+ versus Mg2+.</PubMed_Title>
      <Author>Schweins, T., et al.</Author>
      <Journal>J.Mol.Biol.(1997)266:847-856</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9102473?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of RasA59G in the GTP-bound form</PDB_Title>
      <PDB_ID>1LF0</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LF0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Structural Basis for the Transition from Ras-GTP to Ras-GDP</PubMed_Title>
      <Author>Hall, B.E., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2002)99:12138-12142</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12213964?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Allosteric modulation of H-Ras GTPase</PDB_Title>
      <PDB_ID>3K9N</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3K9N</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00240009</ASD_Ligand>
      <PubMed_Title>Allosteric modulation of Ras positions Q61 for a direct role in catalysis.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:4931-4936</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20194776?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUKTUR UND GUANOSINTRIPHOSPHAT-HYDROLYSEMECHANISMUS DES C-TERMINAL VERKUERZTEN MENSCHLICHEN KREBSPROTEINS P21-H-RAS</PDB_Title>
      <PDB_ID>121P</PDB_ID>
      <Resolution>1.54</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=121P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Struktur Und Guanosintriphosphat-Hydrolysemechanismus Des C-Terminal Verkuerzten Menschlichen Krebsproteins P21-H-Ras</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras crosslinked control, soaked in aqueous solution: one of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RRY</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RRY</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras 166 in Aqueous mother liqour, RT</PDB_Title>
      <PDB_ID>1P2T</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1P2T</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Organic solvents order the dynamic switch II in Ras crystals</PubMed_Title>
      <Author>Buhrman, G.K., et al.</Author>
      <Journal>Structure(2003)11:747-751</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12842038?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of H-Ras T35S in complex with GppNHp</PDB_Title>
      <PDB_ID>3KKN</PDB_ID>
      <Resolution>2.09</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KKN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for conformational dynamics of GTP-bound Ras protein</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTALLOGRAPHIC STUDIES ON P21H-RAS USING SYNCHROTRON LAUE METHOD: IMPROVEMENT OF CRYSTAL QUALITY AND MONITORING OF THE GTPASE REACTION AT DIFFERENT TIME POINTS</PDB_Title>
      <PDB_ID>1PLL</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PLL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic studies on p21(H-ras) using the synchrotron Laue method: improvement of crystal quality and monitoring of the GTPase reaction at different time points.</PubMed_Title>
      <Author>Scheidig, A.J., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1994)50:512-520</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15299412?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE SOLUTION STRUCTURE AND DYNAMICS OF RAS P21. GDP DETERMINED BY HETERONUCLEAR THREE AND FOUR DIMENSIONAL NMR SPECTROSCOPY</PDB_Title>
      <PDB_ID>1CRR</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CRR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy.</PubMed_Title>
      <Author>Kraulis, P.J., et al.</Author>
      <Journal>Biochemistry(1994)33:3515-3531</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8142349?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of H-Ras T35S in complex with GppNHp</PDB_Title>
      <PDB_ID>3KKM</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KKM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for conformational dynamics of GTP-bound Ras protein</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Complex of Ras-GDP with RafRBD(A85K)</PDB_Title>
      <PDB_ID>3KUD</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KUD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf.</PubMed_Title>
      <Author>Filchtinski, D., et al.</Author>
      <Journal>J.Mol.Biol.(2010)399:422-435</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20361980?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of H-Ras-GppNHp</PDB_Title>
      <PDB_ID>2RGE</PDB_ID>
      <Resolution>1.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RGE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Transformation Efficiency of RasQ61 Mutants Linked to Structural Features of the Switch Regions in the Presence of Raf.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Structure(2007)15:1618-1629</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18073111?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Ras soaked in Magnesium Acetate and back soaked in Calcium Acetate</PDB_Title>
      <PDB_ID>3LBI</PDB_ID>
      <Resolution>2.09</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LBI</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Allosteric modulation of Ras positions Q61 for a direct role in catalysis.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:4931-4936</Journal>
      <PubMed_ID>20194776</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>C-H-RAS P21 PROTEIN MUTANT WITH THR 35 REPLACED BY SER (T35S) COMPLEXED WITH GUANOSINE-5'-[B,G-IMIDO] TRIPHOSPHATE</PDB_Title>
      <PDB_ID>1IAQ</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IAQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Dynamic properties of the Ras switch I region and its importance for binding to effectors.</PubMed_Title>
      <Author>Spoerner, M., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2001)98:4944-4949</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11320243?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of H-RasQ61I-GppNHp</PDB_Title>
      <PDB_ID>2RGA</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RGA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Transformation Efficiency of RasQ61 Mutants Linked to Structural Features of the Switch Regions in the Presence of Raf.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Structure(2007)15:1618-1629</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18073111?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of Ras-Bry2RBD complex</PDB_Title>
      <PDB_ID>1K8R</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1K8R</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Ras-Byr2RBD complex: structural basis for Ras effector recognition in yeast.</PubMed_Title>
      <Author>Scheffzek, K., et al.</Author>
      <Journal>Structure(2001)9:1043-1050</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11709168?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE SOLUTION STRUCTURE AND DYNAMICS OF RAS P21. GDP DETERMINED BY HETERONUCLEAR THREE AND FOUR DIMENSIONAL NMR SPECTROSCOPY</PDB_Title>
      <PDB_ID>1CRQ</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CRQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy.</PubMed_Title>
      <Author>Kraulis, P.J., et al.</Author>
      <Journal>Biochemistry(1994)33:3515-3531</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8142349?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Room temperature H-ras</PDB_Title>
      <PDB_ID>3TGP</PDB_ID>
      <Resolution>1.31</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3TGP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Accessing protein conformational ensembles using room-temperature X-ray crystallography.</PubMed_Title>
      <Author>Fraser, J.S., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2011)108:16247-16252</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21918110?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-RasG12V with allosteric switch in the off state</PDB_Title>
      <PDB_ID>3OIV</PDB_ID>
      <Resolution>1.84</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OIV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04400004</ASD_Ligand>
      <PubMed_Title>Allosteric Modulation of Ras-GTP Is Linked to Signal Transduction through RAF Kinase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Biol.Chem.(2011)286:3323-3331</Journal>
      <PubMed_ID>21098031</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GDP (2)</PDB_Title>
      <PDB_ID>2CLD</PDB_ID>
      <Resolution>1.22</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CLD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Newly Designed Microspectrofluorometer for Kinetic Studies on Protein Crystals in Combination with X-Ray Diffraction</PubMed_Title>
      <Author>Klink, B.U., et al.</Author>
      <Journal>Biophys.J.(2006)91:981</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16698776?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX</PDB_Title>
      <PDB_ID>2VH5</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2VH5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Functional Intracellular Antibody Fragments Do not Require Invariant Intra-Domain Disulfide Bonds.</PubMed_Title>
      <Author>Tanaka, T., et al.</Author>
      <Journal>J.Mol.Biol.(2008)376:749</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18187153?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the dominant negative S17N mutant of Ras</PDB_Title>
      <PDB_ID>3LO5</PDB_ID>
      <Resolution>2.57</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LO5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the Dominant Negative S17N Mutant of Ras</PubMed_Title>
      <Author>Nassar, N., et al.</Author>
      <Journal>Biochemistry(2010)49:1970-1974</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20131908?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-RasG12V with allosteric switch in the on state</PDB_Title>
      <PDB_ID>3OIW</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OIW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Allosteric Modulation of Ras-GTP Is Linked to Signal Transduction through RAF Kinase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Biol.Chem.(2011)286:3323-3331</Journal>
      <PubMed_ID>21098031</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA,GAMMA-IMIDO-GTP</PDB_Title>
      <PDB_ID>1RVD</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RVD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Guanosine triphosphatase stimulation of oncogenic Ras mutants.</PubMed_Title>
      <Author>Ahmadian, M.R., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(1999)96:7065-7070</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10359839?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF P21RAS IN COMPLEX WITH GTP AT 100 K</PDB_Title>
      <PDB_ID>1QRA</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QRA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The pre-hydrolysis state of p21(ras) in complex with GTP: new insights into the role of water molecules in the GTP hydrolysis reaction of ras-like proteins.</PubMed_Title>
      <Author>Scheidig, A.J., et al.</Author>
      <Journal>Structure Fold.Des.(1999)7:1311-1324</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10574788?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras in 50% isopropanol</PDB_Title>
      <PDB_ID>1P2U</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1P2U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Organic solvents order the dynamic switch II in Ras crystals</PubMed_Title>
      <Author>Buhrman, G.K., et al.</Author>
      <Journal>Structure(2003)11:747-751</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12842038?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Ras soaked in Magnesium Acetate</PDB_Title>
      <PDB_ID>3LBN</PDB_ID>
      <Resolution>1.86</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LBN</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00240009</ASD_Ligand>
      <PubMed_Title>Allosteric modulation of Ras positions Q61 for a direct role in catalysis.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:4931-4936</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20194776?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras soaked in 55% dimethylformamide: 1 of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RS5</PDB_ID>
      <Resolution>1.68</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RS5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras wildtype new crystal form</PDB_Title>
      <PDB_ID>3L8Z</PDB_ID>
      <Resolution>1.44</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3L8Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Stabilizing a weak binding state for effectors in the human ras protein by cyclen complexes</PubMed_Title>
      <Author>Rosnizeck, I.C., et al.</Author>
      <Journal>Angew.Chem.Int.Ed.Engl.(2010)49:3830-3833</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20401883?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTALLOGRAPHIC STUDIES ON P21H-RAS USING SYNCHROTRON LAUE METHOD: IMPROVEMENT OF CRYSTAL QUALITY AND MONITORING OF THE GTPASE REACTION AT DIFFERENT TIME POINTS</PDB_Title>
      <PDB_ID>1PLJ</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PLJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic studies on p21(H-ras) using the synchrotron Laue method: improvement of crystal quality and monitoring of the GTPase reaction at different time points.</PubMed_Title>
      <Author>Scheidig, A.J., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1994)50:512-520</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15299412?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Ras soaked in Calcium Acetate</PDB_Title>
      <PDB_ID>3LBH</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LBH</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Allosteric modulation of Ras positions Q61 for a direct role in catalysis.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:4931-4936</Journal>
      <PubMed_ID>20194776</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE ACTIVE RAS PROTEIN COMPLEXED WITH THE RAS-INTERACTING DOMAIN OF RALGDS</PDB_Title>
      <PDB_ID>1LFD</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LFD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the interaction of Ras with RalGDS.</PubMed_Title>
      <Author>Huang, L., et al.</Author>
      <Journal>Nat.Struct.Biol.(1998)5:422-426</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9628477?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras soaked in 60% 1,6-hexanediol: 1 of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RS4</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RS4</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras soaked in 20% S,R,S-bisfuranol: 1 of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RSO</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RSO</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES</PDB_Title>
      <PDB_ID>521P</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=521P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules.</PubMed_Title>
      <Author>Krengel, U., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1990)62:539-548</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2199064?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>RAS G12V - PI 3-KINASE GAMMA COMPLEX</PDB_Title>
      <PDB_ID>1HE8</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HE8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure and Functional Analysis of Ras Binding to its Effector Phosphoinositide 3-Kinase Gamma</PubMed_Title>
      <Author>Pacold, M.E., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2000)103:931</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11136978?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>REFINED CRYSTAL STRUCTURE OF THE TRIPHOSPHATE CONFORMATION OF H-RAS P21 AT 1.35 ANGSTROMS RESOLUTION: IMPLICATIONS FOR THE MECHANISM OF GTP HYDROLYSIS</PDB_Title>
      <PDB_ID>5P21</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=5P21</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis.</PubMed_Title>
      <Author>Pai, E.F., et al.</Author>
      <Journal>EMBO J.(1990)9:2351-2359</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2196171?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of GppNHp-bound H-RasT35S mutant protein</PDB_Title>
      <PDB_ID>2LCF</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2LCF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the state 1 conformer of GTP-bound H-Ras protein and distinct dynamic properties between the State 1 and state 2 conformers</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of H-RasQ61V-GppNHp</PDB_Title>
      <PDB_ID>2RGC</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RGC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Transformation Efficiency of RasQ61 Mutants Linked to Structural Features of the Switch Regions in the Presence of Raf.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Structure(2007)15:1618-1629</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18073111?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-RAS 166 in 60 % 1,6 hexanediol</PDB_Title>
      <PDB_ID>1P2V</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1P2V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Organic solvents order the dynamic switch II in Ras crystals</PubMed_Title>
      <Author>Buhrman, G.K., et al.</Author>
      <Journal>Structure(2003)11:747-751</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12842038?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-RAY CRYSTAL STRUCTURE ANALYSIS OF THE CATALYTIC DOMAIN OF THE ONCOGENE PRODUCT P21H-RAS COMPLEXED WITH CAGED GTP AND MANT DGPPNHP</PDB_Title>
      <PDB_ID>1GNR</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GNR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray crystal structure analysis of the catalytic domain of the oncogene product p21H-ras complexed with caged GTP and mant dGppNHp.</PubMed_Title>
      <Author>Scheidig, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1995)253:132-150</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7473708?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of NORE1A in Complex with RAS</PDB_Title>
      <PDB_ID>3DDC</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DDC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II</PubMed_Title>
      <Author>Stieglitz, B., et al.</Author>
      <Journal>Embo J.(2008)27:1995-2005</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18596699?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras soaked in neat cyclopentanol: one of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RS0</PDB_ID>
      <Resolution>1.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RS0</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras 166 in 50% 2,2,2 triflouroethanol</PDB_Title>
      <PDB_ID>1P2S</PDB_ID>
      <Resolution>2.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1P2S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Organic Solvents Order the Dynamic Switch II in Ras Crystals</PubMed_Title>
      <Author>Buhrman, G.K., et al.</Author>
      <Journal>Structure(2003)11:747-751</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12842038?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of RasA59G in the GDP-bound Form</PDB_Title>
      <PDB_ID>1LF5</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LF5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Structural Basis for the Transition from Ras-GTP to Ras-GDP</PubMed_Title>
      <Author>Hall, B.E., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2002)99:12138-12142</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12213964?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF THE CATALYTIC DOMAINS OF NORMAL RAS PROTEIN AND AN ONCOGENIC MUTANT COMPLEXED WITH GSP</PDB_Title>
      <PDB_ID>2Q21</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2Q21</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.</PubMed_Title>
      <Author>Tong, L.A., et al.</Author>
      <Journal>J.Mol.Biol.(1991)217:503-516</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1899707?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Allosteric modulation of H-Ras GTPase</PDB_Title>
      <PDB_ID>3K8Y</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3K8Y</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Allosteric modulation of Ras positions Q61 for a direct role in catalysis.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:4931-4936</Journal>
      <PubMed_ID>20194776</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the activating H-RasK117R mutant in Costello Syndrome, bound to Mg-GDP</PDB_Title>
      <PDB_ID>2QUZ</PDB_ID>
      <Resolution>1.49</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QUZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation.</PubMed_Title>
      <Author>Denayer, E., et al.</Author>
      <Journal>Hum.Mutat.(2008)29:232-239</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17979197?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>H-Ras in 70% glycerol: one of 10 in MSCS set</PDB_Title>
      <PDB_ID>3RRZ</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RRZ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04978008</ASD_Ligand>
      <PubMed_Title>Analysis of Binding Site Hot Spots on the Surface of Ras GTPase.</PubMed_Title>
      <Author>Buhrman, G., et al.</Author>
      <Journal>J.Mol.Biol.(2011)413:773-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21945529?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GTP</PDB_Title>
      <PDB_ID>2CL7</PDB_ID>
      <Resolution>1.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CL7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Newly Designed Microspectrofluorometer for Kinetic Studies on Protein Crystals in Combination with X-Ray Diffraction.</PubMed_Title>
      <Author>Klink, B.U., et al.</Author>
      <Journal>Biophys.J.(2006)91:981</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16698776?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-RAY CRYSTAL STRUCTURE ANALYSIS OF THE CATALYTIC DOMAIN OF THE ONCOGENE PRODUCT P21H-RAS COMPLEXED WITH CAGED GTP AND MANT DGPPNHP</PDB_Title>
      <PDB_ID>1GNQ</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GNQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray crystal structure analysis of the catalytic domain of the oncogene product p21H-ras complexed with caged GTP and mant dGppNHp.</PubMed_Title>
      <Author>Scheidig, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1995)253:132-150</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7473708?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE ACTIVATING H-RAS I163F MUTANT IN COSTELLO SYNDROME, BOUND TO MG-GDP</PDB_Title>
      <PDB_ID>2X1V</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2X1V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Activating H-Ras I163F Mutant in Costello Syndrome, Bound to Mg-Gdp</PubMed_Title>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04068</Pathway_ID>
      <Pathway_Title>FoxO signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05215</Pathway_ID>
      <Pathway_Title>Prostate cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04550</Pathway_ID>
      <Pathway_Title>Signaling pathways regulating pluripotency of stem cells</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05166</Pathway_ID>
      <Pathway_Title>HTLV-I infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04014</Pathway_ID>
      <Pathway_Title>Ras signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04915</Pathway_ID>
      <Pathway_Title>Estrogen signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05219</Pathway_ID>
      <Pathway_Title>Bladder cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04662</Pathway_ID>
      <Pathway_Title>B cell receptor signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04921</Pathway_ID>
      <Pathway_Title>Oxytocin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05161</Pathway_ID>
      <Pathway_Title>Hepatitis B</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04071</Pathway_ID>
      <Pathway_Title>Sphingolipid signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04151</Pathway_ID>
      <Pathway_Title>PI3K-Akt signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04530</Pathway_ID>
      <Pathway_Title>Tight junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04370</Pathway_ID>
      <Pathway_Title>VEGF signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04720</Pathway_ID>
      <Pathway_Title>Long-term potentiation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04010</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04015</Pathway_ID>
      <Pathway_Title>Rap1 signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04726</Pathway_ID>
      <Pathway_Title>Serotonergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04917</Pathway_ID>
      <Pathway_Title>Prolactin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05223</Pathway_ID>
      <Pathway_Title>Non-small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04012</Pathway_ID>
      <Pathway_Title>ErbB signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04916</Pathway_ID>
      <Pathway_Title>Melanogenesis</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04912</Pathway_ID>
      <Pathway_Title>GnRH signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05218</Pathway_ID>
      <Pathway_Title>Melanoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04650</Pathway_ID>
      <Pathway_Title>Natural killer cell mediated cytotoxicity</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05211</Pathway_ID>
      <Pathway_Title>Renal cell carcinoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05213</Pathway_ID>
      <Pathway_Title>Endometrial cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04725</Pathway_ID>
      <Pathway_Title>Cholinergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04540</Pathway_ID>
      <Pathway_Title>Gap junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05219</Pathway_ID>
      <Pathway_Title>Bladder cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05221</Pathway_ID>
      <Pathway_Title>Acute myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04810</Pathway_ID>
      <Pathway_Title>Regulation of actin cytoskeleton</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell motility</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05216</Pathway_ID>
      <Pathway_Title>Thyroid cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04014</Pathway_ID>
      <Pathway_Title>Ras signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04660</Pathway_ID>
      <Pathway_Title>T cell receptor signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04722</Pathway_ID>
      <Pathway_Title>Neurotrophin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05160</Pathway_ID>
      <Pathway_Title>Hepatitis C</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05220</Pathway_ID>
      <Pathway_Title>Chronic myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04014</Pathway_ID>
      <Pathway_Title>Ras signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05231</Pathway_ID>
      <Pathway_Title>Choline metabolism in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04910</Pathway_ID>
      <Pathway_Title>Insulin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04664</Pathway_ID>
      <Pathway_Title>Fc epsilon RI signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05216</Pathway_ID>
      <Pathway_Title>Thyroid cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04510</Pathway_ID>
      <Pathway_Title>Focal adhesion</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04915</Pathway_ID>
      <Pathway_Title>Estrogen signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04919</Pathway_ID>
      <Pathway_Title>Thyroid hormone signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04730</Pathway_ID>
      <Pathway_Title>Long-term depression</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04360</Pathway_ID>
      <Pathway_Title>Axon guidance</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Development</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05230</Pathway_ID>
      <Pathway_Title>Central carbon metabolism in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04062</Pathway_ID>
      <Pathway_Title>Chemokine signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.fb.b.bb.b.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/121p</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,97,Arg;site,108,Asp;site,109,Val;site,137,Tyr</Site_Detail>
      <Site_Reference>Buhrman G, et al. Proc Natl Acad Sci U S A. 2010,107(11):4931-4936.</Site_Reference>
      <Site_Type>Allosteric switch</Site_Type>
      <PubMed_ID>20194776</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00240007</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00240009</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00290006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01100001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04400004</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04978003</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04978008</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD11630001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>